An interventional study of Vancomycine in Catheter-Related Infections, sponsored by Universität des Saarlandes. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-12-15.
Sponsored by Universität des Saarlandes · Not applicable, Interventional, and Prevention
The goal of this prospective interventional study is to evaluate the impact of antibiotic prophylaxis on bloodstream infections after liberation of extracorporeal membrane oxygenation therapy. The main questions aims to answer are:
Participants will get 1 dose of vancomycine I.V. (15-20 mg per kgKG) prior to liberation of ECMO.
Researchers will compare this interventional group to a group without antibiotic prophylaxis.
108 studies on the registry are indexed under Catheter-Related Infections; 17 are open to participants now.
This study's planned enrollment of 42 is below the median of 150 across 77 interventional studies indexed under Catheter-Related Infections.
Browse Catheter-Related Infections studies →Universität des Saarlandes is the lead sponsor of 68 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Application of 15-20 mg per kgKG Vancomycine I.V. prior to ECMO liberation
Drug: Vancomycine
Control group - no intervention.
Application of 15-20 mg per kgKG Vancomycine I.V. prior to ECMO liberation
Growth of pathogens in blood culture
Detection of pathogens / blood stream infection
Time frame: taken 72 hours after liberation of extracorporeal membrane oxygenation therapy
Growth of pathogens in blood culture
Detection of pathogens / blood stream infection
Time frame: taken directly before removal of extracorporeal membrane oxygenation therapy
Growth of pathogens on cannula tip
Detection of growth of pathogens on cannulas
Time frame: on the day of liberation, cannula tip will be send to institute of microbiology directly after liberation from ECMO
laboratory parameters
leukocytes, procalcitonin, C-reactive protein
Time frame: 6.00 am on the day of liberation of extracorporeal membrane oxygenation therapy
laboratory parameters
leukocytes, procalcitonin, C-reactive protein
Time frame: 24 hours after liberation of extracorporeal membrane oxygenation therapy
laboratory parameters
leukocytes, procalcitonin, C-reactive protein
Time frame: 48 hours after liberation of extracorporeal membrane oxygenation therapy
laboratory parameters
leukocytes, procalcitonin, C-reactive protein
Time frame: 72 hours after liberation of extracorporeal membrane oxygenation therapy
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Vancomycin
Universität des Saarlandes